FDA Pushes Clinical Trial Transparency in 2026
Nearly 30% of clinical trials required to report results never submitted data to ClinicalTrials.gov, prompting FDA enforcement letters in April 2026.
Clinical Research
12 articles tagged "Clinical Research"
The Future of Preconception Health: Progress and Gaps
Eight years after the 2018 Lancet Series, preconception health has evolved conceptually but faces real barriers to full clinical implementation.
FDA Seeks New Powers Over Drug Ads in 2026
The FDA is requesting expanded statutory authority over direct-to-consumer drug ads in its FY2027 budget, targeting misleading pharmaceutical promotions.
BMJ Retracts PREVENT-TAHA8 Stem Cell Heart Failure Trial
The BMJ has retracted the PREVENT-TAHA8 phase 3 trial on mesenchymal stem cells for heart failure due to data integrity and enrollment concerns.
By James Liu
Insmed's Arikayce Succeeds in Phase 3 MAC Lung Trial
Insmed's Arikayce met primary endpoints in a phase 3 trial for treatment-naive MAC lung infection patients, improving symptoms and culture conversion rates.
By James Liu
Fall Prevention in Stroke Survivors: Tailored Interventions Work
Stroke survivors face 1.5x higher fall risk. New Australian trial evidence supports home-based, individualized programs to reduce falls in this vulnerable group.
By Sarah Tanaka
Rethinking eGFR Monitoring in Chronic Kidney Disease
New evidence challenges single eGFR measurements in CKD, suggesting GFR decline trajectory is more clinically actionable than point-in-time precision.
By Sarah Tanaka
Iran Conflict, Pharma Supply Chain & Pfizer Lyme Vaccine
Analysts warn Iran conflict could disrupt pharma supply chains via Strait of Hormuz, while Pfizer's Lyme disease vaccine shows promise in Phase 3 trials.
By Sarah Tanaka
Surgical Approach and Long-Term Lung Cancer Outcomes 2026
A Lancet commentary argues surgical technique is a key variable in lung cancer outcomes, urging rigorous trial design to evaluate minimally invasive approaches.
Aldeyra Therapeutics FDA Review: Red Flags & Short Sellers
Aldeyra Therapeutics faces FDA scrutiny amid short-seller pressure as its regulatory decision window approaches. What clinicians need to know in 2026.
By James Liu
Rising Autism & ADHD Diagnoses: Awareness or True Increase?
Global ASD and ADHD diagnoses have surged over two decades. Evidence suggests this reflects correcting historic underdiagnosis, not a true prevalence increase.
By James Liu
FDA Reduces Advisory Meetings Amid Controversial Decisions
The FDA is cutting back on public advisory committee meetings as contested drug approval decisions mount, raising transparency concerns for patients nationwide.
By Priya Patel